Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opioid Mechanisms of Affective Touch
NCT03096353Phase 1Completed
- Sponsor
- National Center for Complementary and Integrative Health
- Start
- Aug 2017
- Primary completion
- Oct 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of naloxone (2 arms), sponsored by National Center for Complementary and Integrative Health. Primary endpoint: Change in Pleasantness of Skin Brushing From Before to After Infusion at 1 day. Started Aug 2017; status: completed.
02
Drugs
naloxone
Beyond the preview
Go deeper on NCT03096353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03096353.